Vicarious Surgical, Inc. · OTC:RBOT

Vicarious Surgical — Investor Presentation (November 2023)

22 slides from Vicarious Surgical's investor presentation, Nov 13, 2023

  1. Slide 1: Investor Presentation November 2023

    INVESTOR PRESENTATION NOVEMBER 2023

  2. Slide 2: Disclaimer

    0 0 | SUMMA R Y VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 2 DISCLAIMER This presentation includes “forward - looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The company’s actual results may dif

  3. Slide 3: Key Investment Highlights

    0 0 | SUMMA R Y VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 3 KEY INVESTMENT HIGHLIGHTS 1 VICARIOUS SURGICAL ESTIMATES FROM DATA SOURCED FROM LSI MARKET SIZE ANALYSIS 2022 DATA AND PUBLIC FILINGS. ASSUMES $3,319 REVENUE PER PROCEDURE CURRENTLY REALIZED BY LEGACY ROBOTIC COMPANY. 2 PARTNER

  4. Slide 4: Surgery Today

    SURGERY TODAY 1 VICARIOUS SURGICAL ESTIMATES FROM DATA SOURCED FROM LSI MARKET SIZE ANALYSIS 2022 DATA AND PUBLIC FILINGS. ASSUMES $3,319 REVENUE PER PROCEDURE CURRENTLY REALIZED BY LEGACY ROBOTIC COMPANY. 2 VICARIOUS SURGICAL ESTIMATES FROM LSI MARKET DATA. 2022 DATA 3 DHARAP SB, BARBANIYA P, NAVGA

  5. Slide 5: The Vicarious Surgical System

    VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 5 T H E VICARIOU S SURGICA L S Y S TEM 01

  6. Slide 6: The System

    VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 6 0 1 | TH E VI C ARIOU S SURGI C A L S Y S TEM THE SYSTEM 1 VICARIOUS SURGICAL SYSTEM IS CAPABLE OF TROCAR SIZES AS LOW AS 1.2CM. CURRENT DISPOSABLES REQUIRE 1.8CM TROCAR. 2 INCLUDES ADDITIONAL FEATURES EXPECTED AFTER INITIAL LAUNCH AND NECESSA

  7. Slide 7: Unwanted Force Build-Up

    1 UN W ANTED FORCE BUILD - UP 1x 50x 20x 2 3 4 5 6 7 8 9 40x 30x 10x EXISTING SURGICAL ROBOTS IF THEY H A D 5 + DEGREE S OF FREED O M I N TH E B O D Y DECOUPLED ACTUATORS: OUR ENABLING TECHNOLOGY PROPRIETARY TECHNOLOGY: • ISOLATES CABLE PATHWAYS • REMOVES BUILD UP OF FORCE BETWEEN JOINTS CABLE BREAK

  8. Slide 8: One Small Incision

    ONE SMALL INCISION 0.5 - 1.5cm INCISIONAL COMPLICATION R A T E 20% 10% 1.8cm INCISION SIZE MINIMIZING PATIENT COMPLICATIONS THROUGH 1.8CM TROCAR 1 • <2.0CM INCISION ABILITY TO UTILIZE OBTURATOR • >2.0CM INCISION REQUIRES SCALPEL • OBTURATOR DRIVES COMPLICATION RATES DOWN BY SEPARATING MUSCLE FIBERS

  9. Slide 9: Unrestricted Surgeon Workspace

    UNRESTRICTED SURGEON WORKSPACE NEARLY 360 ƒ WORKSPACE IN THE ABDOMEN THROUGH ONE 1.8CM 1 TROCAR THE 13 DEGREES OF FREEDOM POWERED BY PROPRIETARY DECOUPLED MOTION PROVIDES SURGEONS UNPRECEDENTED DEXTERITY AND RANGE OF MOTION LEGACY SYSTEMS HAVE LIMITED WORKING AREA COLLISIONS INSIDE AND OUTSIDE THE P

  10. Slide 10: Sensing and Visualization

    SENSING AND VISUALIZATION COLLECTING HIGH QUALITY DATA: THE KEY TO ENABLE SURGEON DECISION SUPPORT, MACHINE LEARNING, AND BROADER AI CAPABILITY 1 0 1 | TH E VI C ARIOU S SURGI C A L S Y S TEM 10 MEASUREMENT OF FORCE AND POSITION WITH SENSORS FROM WITHIN ABDOMINAL CAVITY DECOUPLED ACTUATORS ENABLE UN

  11. Slide 11: Attractive Cost Model

    11 0 1 | TH E VI C ARIOU S SURGI C A L S Y S TEM ATTRACTIVE COST MODEL • Capital equipment is primarily non - robotic as movement is ge n e r a t ed f r om within t h e a b do m en • Cost of goods of capital equipment is expected to be significantly l o w er than c om p e ting p r oduct s 1 • Decoup

  12. Slide 12: Future of Surgery

    VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 12 FUTUR E OF SURGERY 02

  13. Slide 13: Transforming Robotics to Become the Standard of Care

    TRANSFORMING ROBOTICS TO BECOME THE STANDARD OF CARE 1 DHARAP SB, BARBANIYA P, NAVGALE S. INCIDENCE AND RISK FACTORS OF POSTOPERATIVE COMPLICATIONS IN GENERAL SURGERY PATIENTS. CUREUS. 2022 NOV 1;14(11):E30975. DOI: 10.7759/CUREUS.30975. PMID: 36465229; PMCID: PMC9714582. 2 INCLUDES ADDITIONAL FEATU

  14. Slide 14: Pioneering Automated Patient Protection

    PIONEERING AUTOMATED PATIENT PROTECTION 1 TO GENERATE IMPROVED PATIENT OUTCOMES BUILDING TOWARDS PROCEDURAL AUTOMATION PROCEDU R AL AUTOMATION Our pl a t f orm is uniquely engi n ee r ed t o deli v er r eliabl e , r e p e a table re sults th r ough futu r e “ au t opil o t” au t om a tion UNIQUE SYS

  15. Slide 15: Pathway to Commercialization

    VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 15 P A TH W A Y T O COMMERCIALIZATION 03

  16. Slide 16: Hospital System Partners

    HOSPITAL SYSTEM PARTNERS KEY PARTNERSHIPS WITH FOUR LEADING HEALTHCARE PROVIDERS REPRESENTING OVER 250 HOSPITALS AND 200 SURGERY CENTERS CREATING THE FOUNDATION FOR A STRONG COMMERICAL LAUNCH CLINICAL EXECUTION Joint si t e selection a n d clinical trial sup p o r t f or F D A submi s sion PLATFORM

  17. Slide 17: Indication Pathway and Initial Market Value

    1 COLORECTAL, SMALL BOWEL, BARIATRIC, ESOPHAGEAL, BARIATRIC, STOMACH (NON - ENDOSCOPIC), LSI WW 2022 DATA 2 VICARIOUS SURGICAL ESTIMATES FROM LSI WW 2022 DATA, INCLUDES SOME PATIENTS WHO CHOSE TO NOT HAVE HERNIAS REPAIRED WITH LEGACY TECHNIQUES 3 LSI WW 2022 DATA 4 HYSTERECTOMY, OOPHORECTOMY, COLPOP

  18. Slide 18: Our Roadmap

    0 3 | P A TH W A Y T O COMMERCIALIZ A TION 18 20 2 3 NOTE: ACTUAL MILESTONES AND TIMELINE MAY VARY AS CERTAIN ACTIVITIES ARE BEYOND VICARIOUS SURGICAL’S CONTROL F D A De N o v o Submission Fi r s t Clinical Patient V e r sion 1 . 0 D e sign Lock H C A & UH C en t e r s o f E x c elle n c e Manu f ac

  19. Slide 19: Team and Investors

    T E A M A N D IN V E S T O R S 04 VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 19

  20. Slide 20: Our Team and Investors

    0 4 | OU R TEA M A N D IN V E S T ORS VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 20 EXPERIENCED MANAGEMENT TEAM CO - FOUNDER, CHIEF TECHNOLOGY OFFICER SAMMY KHALIFA CO - FOUNDER, CHIEF EXECUTIVE OFFICER ADAM SACHS CHIEF FINANCIAL OFFICER BILL KELLY CHIEF OPERATING OFFICER JOHN MAZZOLA VP

  21. Slide 21: Experienced Board and Advisors

    EXPERIENCED BOARD AND ADVISORS SEASONED IN V E S T OR S 1 Bill G a t e s EXECUTIVE CHAIRMAN DAVID STYKA BOARD DIRECTOR DAVID HO BOARD DIRECTOR SAMMY KHALIFA BOARD DIRECTOR ADAM SACHS BOARD DIRECTOR BEVERLY HUSS BOARD DIRECTOR DONALD TANG BOARD DIRECTOR RIC FULOP F or m er O p e r a tional L e ader a

  22. Slide 22: Thank You

    VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 T H AN K Y OU 78 F ou r th A v enue W altha m , MA, 024 5 1 vicariou s su r gical . c om +1.617.868.1700 VICARIOUS SURGICAL 22

Vicarious Surgical — Investor Presentation (November 2023) on 6ix